Frankfurt - Delayed Quote EUR
Zymeworks Inc. (ZA8.F)
10.80
+1.00
+(10.20%)
As of 3:29:01 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 7 |
| Avg. Estimate | 20.65M | 18.02M | 94.41M | 149.03M |
| Low Estimate | 8.6M | 8.6M | 53.2M | 46.4M |
| High Estimate | 40M | 27M | 126M | 313.26M |
| Year Ago Sales | 10.03M | 19.24M | 76.3M | 94.41M |
| Sales Growth (year/est) | 105.92% | -6.34% | 23.73% | 57.86% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZA8.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Initiated | LifeSci Capital: Outperform | 3/11/2025 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/10/2025 |
| Maintains | Citigroup: Buy to Buy | 3/7/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/19/2024 |
| Upgrade | JP Morgan: Neutral to Overweight | 12/16/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/22/2024 |